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Abstract
Background: Hormonal disorders are frequently present in haemodialysed patients with chronic kidney disease (CKD). In women with 
CKD sex hormone abnormalities may lead to irregular, often anovulatory cycles, sexual dysfunction, and infertility. Kidney transplanta-
tion (KTx) in young women tends to ameliorate most of the aforementioned disorders and improve fertility. The aim of this study was to 
assess the changes of serum sex hormone concentrations in young women before and six months after successful KTx 
Materials and methods: Fourteen chronic haemodialysis women with CKD undergoing kidney transplantation and 46 apparently healthy 
women in similar age (control group) were enrolled into the study. In all women serum concentrations of FSH, LH, PRL, and oestradiol 
were determined. Measurements in the transplanted group were done four times: immediately before surgery, in the 14th and 30th day, 
and six months after the transplantation. The results are presented as means and 95% CI. 
Results: All of the women that completed the study presented excellent function of the transplanted kidney — mean serum creatinine 
concentration was 92.54 (74.85–110.23) µmol/l. After successful KTx a significant decrease in the serum concentrations of FSH and LH was 
observed. The decrease of serum PRL concentration after KTx did not reach statistical significance in the multiple comparisons analyses 
but returned to the values observed in healthy controls. KTx did not significantly influence serum oestradiol concentration. 
Conclusions: Successful kidney transplantation leads to the normalisation of serum concentrations of hormones linked to fertility disorders 
in women with chronic kidney disease. (Endokrynol Pol 2018; 69 (2): 150–155)
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Streszczenie
Wstęp: U chorych z przewlekłą chorobą nerek (chronic kidney disease, CKD) poddawanych hemodializie często obserwuje się zaburzenia 
hormonalne. U kobiet z CKD nieprawidłowe stężenia hormonów płciowych mogą powodować nieregularne, często bezowulacyjne cykle, 
zaburzenia czynności seksualnych i bezpłodność. Po przeszczepieniu nerki u młodych kobiet zwykle następuje złagodzenie większości 
z tych zaburzeń i poprawa płodności. Badanie przeprowadzono w celu oceny zmian stężeń hormonów płciowych w surowicy oznaczo-
nych przed i po udanym przeszczepieniu nerki. 
Materiały i metody: Do badania włączono 14 przewlekle hemodializowanych kobiet z CKD, u których planowano przeszczepienie 
nerki oraz 46 zdrowych kobiet w podobnym wieku (grupa kontrolna). U wszystkich kobiet oznaczono stężenia w surowicy hormonu 
folikulotropowego (follicle-stimulating hormone, FSH), hormonu luteinizującego (luteinizing hormone, LH), prolaktyny (prolactin, PRL) 
i estradiolu. W grupie poddanej transplantacji pomiary wykonano 4-krotnie: bezpośrednio przed zabiegiem, w 14. i 30. dobie po zabiegu 
oraz 6 miesięcy po zabiegu. Wyniki przedstawiono jako średnie i 95-procentowe przedziały ufności. 
Wyniki: U wszystkich kobiet, które ukończyły badanie stwierdzono bardzo dobrą czynność przeszczepionej nerki — średnie stężenie 
kreatyniny w surowicy wynosiło 92,54 (74,85–110,23) µmol/l. Po udanym przeszczepieniu nerki zaobserwowano istotne zmniejszenie stężeń 
w surowicy FSH i LH. Zmniejszenie stężenia PRL w surowicy po przeszczepieniu nerki nie osiągnęło poziomu istotności statystycznej 
w testach wielokrotnych porównań, ale stężenie tego hormonu wróciło do wartości obserwowanych u zdrowych osób z grupy kontrolnej. 
Przeszczepienie nerki nie wpłynęło istotnie na stężenie estradiolu w surowicy. 
Wnioski: Zakończone powodzeniem przeszczepienie nerki powoduje normalizację stężeń w surowicy hormonów związanych z zabu-
rzeniami płodności u kobiet z CKD. (Endokrynol Pol 2018; 69 (2): 150–155)
Słowa kluczowe: przewlekła choroba nerek, przeszczepienie nerki, hormony płciowe
Introduction
Disturbances of function of most endocrine glands 
are common in patients with chronic kidney disease 
(CKD). The aetiology of such disturbances is diverse 
and may arise from the impaired production, secretion, 
or metabolism of various hormones by dysfunctional 
kidneys [1–4].
Disturbances of the hypothalamic–pituitary–ovar-
ian axis occur early in the course of CKD and tend 
to progress after the initiation of haemodialysis or 
peritoneal dialysis [5–9]. In CKD women the loss of 
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Nevertheless, this is still about 10 times less frequent 
than in the general population [20]. 
There have been very few studies conducted so 
far that prospectively assess the serum sex hormone 
concentrations in young women immediately before 
and after kidney transplantation (KTx). Thus, the aim 
of this study was to assess the serum concentration of 
these hormones in women with terminal renal failure 
requiring renal replacement treatment and then again 
in the early period after successful KTx. 
Materials and methods
Fourteen young women with CKD stage 5D (age 
18–40 years) treated with haemodialysis or peritoneal 
dialysis were enrolled into the study (study group). 
Additionally, 46 apparently healthy women in similar 
age were enrolled into this study as a control group. 
None of the enrolled women used hormonal replace-
ment therapy or oral contraception, exogenous gluco-
corticoids, or any medication that could influence the 
serum PRL concentration within the three months 
preceding enrolment. No history of thyroid diseases 
was present in 9 of 10 subjects enrolled to the study, 
and their thyroid stimulating hormone (TSH) concen-
tration assessed during the tests necessary before the 
application to the transplantation program, was within 
the normal ranges. One of the enrolled women was 
on levothyroxine substitution and was euthyreotic 
pre- and postoperatively.
All women from the study group underwent 
a deceased-donor kidney transplantation. During the 
observation period four of the enrolled women were 
excluded from the follow-up due to loss of the trans-
planted kidney function during the first two months 
after the surgery.
Eight of the 10 remaining subjects were treated be-
fore kidney transplantation with haemodialysis (among 
them seven had arterio-venous shunt as a vascular 
access for haemodialysis and one had a permanent 
venous catheter), and two females were treated with 
continuous ambulatory peritoneal dialysis (CAPD). Two 
of the 10 females who finished the study had a kidney 
transplanted for the second time (re-transplantation), 
and for the remaining eight it was the first transplanta-
tion procedure.
The aetiology of CKD in this group was: chronic glo-
merulonephritis (four cases), diabetic nephropathy (two 
cases), vasculitis (one case), polycystic kidney disease 
(one case), and Alport’s syndrome (one case). Six of the 
women who finished the study were previously preg-
nant, among them one female more than once. Four of 
the pregnancies ended with a miscarriage, and in one 
case it was during the renal replacement treatment. 
pulsatile gonadotropin secretion in the hypothalamus 
occurs, which leads to disturbances in the cyclic release 
of gonadotropins from the pituitary gland [7, 10–12]. 
This is why the regularity of serum follicle-stimulating 
hormone (FSH), luteinising-hormone (LH), and ovar-
ian steroids fluctuations, typical for a normal menstrual 
cycle, are disrupted. 
Young CKD female patients present normal, or more 
often slightly elevated basal serum LH concentration, 
but the pre-ovulatory peak of serum LH concentration 
is blunted [5, 7]. Serum FSH concentrations in haemo-
dialysed women are usually normal [6, 13–15], thus the 
serum LH/FSH ratio is commonly increased. In young 
women with CKD the impairment of hormonal func-
tion of the ovaries may lead to the reduction in serum 
oestrogen concentration [5, 7]. Thus, in haemodialysed 
CKD women under 40 years of age, primary ovarian 
insufficiency is more common than in the general popu-
lation [16] and menopause occurs 4.5 years earlier than 
in healthy women [9, 17]. 
The alterations of the inhibition of pituitary gland 
hormone secretion leads to overproduction of prolactin 
(PRL) and impaired diurnal rhythm of PRL release [9, 
16, 18]. Hyperprolactinaemia is common in CKD; it 
occurs in about 70% women in CKD stage 5 [19]. This 
is due to the aforementioned overproduction, reduced 
metabolism, and decreased excretion of PRL by the 
kidneys [19, 20]. Increased serum PRL concentration is 
one of the major factors contributing to the dysregula-
tion of the hypothalamic–pituitary–ovarian axis in 
these patients. 
Hormonal disturbances observed in females re-
ceiving renal replacement treatment are the cause of 
irregular, usually anovulary menstrual cycles and con-
comitant fertility disorders [5, 16, 21]. Moreover, even 
in women with preserved ovulation, the luteal phase 
is often shortened [7, 22]. 
All of the aforementioned endocrine disturbances 
and concomitant disorders in sexual functions (e.g. less 
frequent sexual intercourse and loss of libido) in women 
with CKD lead to the impairment of fertility, which is 
most pronounced in stage 5 of CKD [23, 24]. Pregnancy 
is rare in haemodialysed females — its prevalence be-
ing 0.3/100 females/year, which is 40 times less common 
than in the general population. Kidney transplantation 
(KTx) is the treatment of choice in patients with terminal 
renal failure and usually leads to the reduction of the 
disturbances of the menstrual cycle [10–12], as well as 
the improvement of fertility [20, 25, 26]. In about 60% 
of women after successful KTx regular menstrual cyc-
les are observed, while only 30% of women receiving 
renal replacement treatment have regular menstrual 
cycles [26, 27]. Pregnancy is four times more common 
in woman after KTx than in women on haemodialysis. 
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A meticulous medical history (including menstrua-
tion and fertility disorders, number of pregnancies, and 
the actual day of the menstrual cycle during the exami-
nation) was obtained from all of the enrolled women 
from both the study group and the healthy controls. 
Menstrual cycles lasting 29 ± 3 days were regarded as 
regular. A lack of menstrual bleeding for more than six 
months was classified as amenorrhoea.
In the study group, blood samples for laboratory 
analyses were collected four times: just before the pro-
cedure, in the 14th and 30th day after the surgery, and 
then six months after the transplantation. In the healthy 
controls, blood samples for analysis were collected once 
— the sample collection was in the follicular or luteal 
phase. Blood samples were not collected during ovula-
tion. After collection, blood samples were centrifuged, 
aliquoted, and stored at –70oC until assay. 
In all patients the serum creatinine concentration 
was measured using a Beckman-Coulter UniCel DxC 
600 analyser. The estimated glomerular filtration rate 
(eGFR) was calculated using the MDRD formula. Al-
bumin and high-sensitivity C-reactive protein (CRP) 
concentrations were measured by ELISA: albumin — 
Assaypro LLC, St. Charles, USA; CRP — Immundiag-
nostik AG, Bensheim, Germany). Serum concentrations 
of FSH, LH, PRL, and oestradiol were assessed using an 
ECL assay (Roche Diagnostics, Mannheim, Germany). 
The intermediate precision for the PRL assay was 
2.8–5.0%, and the measuring range was 1–10,000 µIU/ml. 
The respective values for the oestradiol assay were 
4.3–9.9% and 5.0–4300.0 pg/ml (functional sensitivity 
12 pg/ml). For FSH assay the intra assay coefficient of 
variation (CoV) was 1.5–1.8% and the intermediate pre-
cision was 3.8–5.3%; the measuring range was 0.1–200.0 
mIU/ml. For the LH assay the respective values were: 
0.8–1.8% and 2–5.2% and 0.1–200.0 mIU/ml.
The study protocol, adherent to the declaration of 
Helsinki, was approved by the Ethics Committee of 
the Medical University of Silesia (KNW/0022/KB1/81/11 
and KNW/0022/KB1/82/11), and all patients gave in-
formed, written consent for participation in the study. 
The study was supported by a research grant from 
the Medical University of Silesia — contract number: 
KNW-1-196/N/5/0.
Statistical analyses
Statistical analyses were performed using the follow-
ing software: Statistica 10.0 PL (Statsoft Polska, Cracow, 
Poland) and PQStat (PQStat Software, Poznan, Poland). 
The Shapiro-Wilk test was used to assess the distribu-
tion of variables. Because most of the analysed variables 
presented skewed distribution, non-parametric tests 
were used. The statistical significance of the differences 
between groups was assessed using the Mann-Whitney 
U-test, and longitudinal analyses were performed using 
Friedman’s ANOVA with Dunn post-hoc correction for 
multiple comparisons. Results are presented as means 
with 95% confidence interval, and the differences were 
considered significant when p < 0.05
Results
A significant decrease in the creatinine concentration 
after successful kidney transplantation was observed. 
The decrease in serum creatinine concentration reached 
the level of significance (after a correction for multiple 
comparisons) a month after the procedure (Table I). The 
eGFR values on the 14th and 30th day and six months af-
ter transplantation were 56.1 (39.6–72.7) ml/min/1.73 m2, 
65.1 (49.4–80.8) ml/min/1.73 m2, and 69.0 (54.9–83.1) ml/
min/1,73 m2, respectively. 
Moreover, a significant (p = 0.034) decrease of se-
rum CRP concentration and increase of serum albumin 
concentration (p = 0.008) after KTx was found (Table I).
During the observation period the serum concen-
tration of both the LH and FSH decreased significantly 
(Table I). This is why there were no significant changes 
observed in the FSH/LH ratio during the study period. 
The serum concentration of PRL was lower at the end of 
the study than at the beginning of the observation, but 
the difference did not reach statistical significance after 
correction for multiple comparisons (Table I). Moreover, 
there was no significant difference in the oestradiol 
concentration during the study period. 
As far as regular menstruation is concerned, before 
the procedure five women had regular menstrual cyc-
les, and in the remaining five menses were irregular. 
Six months after the transplantation procedure regular 
menstrual cycles returned in three women, thus only 
two out of the 10 subjects had irregular menstrual 
cycles (Table II).
In the analyses comparing the study group and the 
control group no differences in age and the time of first 
menstruation (Table II) were found. BMI was signifi-
cantly lower in women before transplantation. Also, the 
irregularities of menstrual cycles were more common 
in the group of women with kidney failure (Table II).
Serum concentrations of urea, glucose, and triglyc-
erides were significantly higher in the group before 
transplantation, in comparison to values obtained in 
healthy females (p < 0.001, p = 0.014, and p < 0.001, 
respectively — Table III). On the other hand, blood 
haemoglobin and serum total protein concentration 
were significantly lower in females from the study 
group before KTx (p < 0.001 and p = 0.002, respectively 
— Table III).
A comparison of the study group and healthy con-
trols at baseline revealed clear differences in serum 
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creatinine concentration (p < 0.001). The studied group 
was also characterised by higher serum concentration of 
CRP and lower albuminaemia (p = 0.02 and p < 0.001, 
respectively — Table I).
As far as the concentration of serum hormones is 
concerned, no significant differences in the serum con-
centrations of oestradiol and FSH between the groups 
were observed (p = 0.36 and p = 0.2, respectively). 
Nonetheless, the studied group presented significantly 
higher serum PRL and LH concentrations (p = 0.046 
and p < 0.001, respectively). Also, the LH/FSH ratio 
was significantly higher in the studied group than in 
the control group (Table I).
A comparison of the study group and healthy con-
trols done six months after successful KTx revealed 
persisting differences in serum creatinine concentra-
tions (p = 0.008). On the other hand, after the half-year 
observation period the studied group was characterised 
by lower serum CRP concentration (p = 0.036 — Table 
1). There were no significant differences in albumi-
naemia found between the groups after the six-month 
observation period (p = 0.08). 
There were no significant differences in the serum 
concentration of oestradiol between the controls and 
women after KTx at the end of the observation period. 
Conversely, a significantly lower serum FSH con-
centration in the transplanted women was observed 
(p = 0.02 — Table I). Additionally, no significant dif-
ferences between the groups in the serum PRL or LH 
concentration was seen (p = 0.3 and p = 0.36 — Table 
III). Nevertheless, the LH/FSH ratio was significantly 
higher in the studied group than in the control group.
Discussion
Several different disorders of the endocrine glands are 
observed in patients with CKD, including deregula-
tion of the hypothalamic — pituitary — ovarian axis 
[2, 5–8, 13]. 
The normalisation of sex hormone secretion after 
successful kidney transplantation leads to the correct 
Graafian follicle maturation, ovulation, and luteinisa-
tion. Moreover, it leads to the improvement of the 
concentration profile of sex hormones due to the 
Table I. Serum concentrations of: creatinine, albumin, CRP, LH, FSH, PRL, and oestradiol in healthy women (control group) 
and in CKD women during the 6-month observation period after kidney transplantation. Statistical differences between study 
group and control group are presented in the text
Tabela I. Stężenia kreatyniny, albuminy CRP, LH, FSH, PRL i estradiolu w surowicy u zdrowych kobiet (grupa kontrolna) 
i kobiet z CKD w trakcie 6-miesięcznej obserwacji po przeszczepieniu nerki
Control group Studied group
before KTx 14th day  
after KTx
30th day  
after KTx
6 months  
after KTx
p#
Creatinine [µmol/l] 59.90 
(56.35–63.45)
536.32
(330.60–42.04)
140.93
(43.24–238.62)
102.81$
(69.45–136.17)
92.54$
(74.85–110.23)
< 0.001
Albumin [g/dl] 3.45 
(3.27–3.63)
3.27
(2.85–3.69)
3.06 
(2.61–3.51)
3.20 
(2.86–3.54)
3.44 
(3.12–3.76)
0.008
CRP [mg/l] 5.92 
(3.99–7.84)
3.46 
(1.26–5.66)
22.33
(from –5.78 to 50.44)
7.08 
(from –0.12 to 14.28)
0.60
(0.21–0.99)
0.034
LH [mIU/ml] 7.29
(6.10–8.49)
17.77 
(11.04–24.50)
10.99 
(2.71–19.27)
12.75
(4.43–21.07)
8.79 
(5.50–12.08)
0.036
FSH [mIU/ml] 5.82
(5.17–6.47)
4.84 
(4.36–5.32)
3.08*
(2.35–3.81)
3.93 
(2.64–5.22)
4.00 
(3.09–4.91)
0.031
LH / FSH 1.38
(1.14–1.62)
3.65 
(2.27–5.04)
3.31 
(1.44–5.18)
2.91 
(1.29–4.54)
2.26 
(1.49–3.02)
0.564
PRL [µIU/ml] 369.70
(312.25–427.14)
875.80 
(103.20–1648.40)
541.70 
(106.23–977.17)
407.30
(261.94–552.66)
355.1
(188.13–522.07)
0.095
Oestradiol [pg/ml] 112.00 
(78.94–145.06)
145.10
(67.30–222.90)
140.70 
(8.99–272.41)
154.80 
(13.56–296.04)
141.30 
(95.31–187.29)
0.392
*p < 0.05 vs. before transplantation
$p < 0.001 vs. before transplantation
#p for ANOVA in the study group
KTx — kidney transplantation, LH — luteinizing hormone, FSH — foliculotropic hormone, PRL — prolactin 
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decrease of improperly elevated serum FSH, LH, and 
PRL concentrations and the increase of improperly low-
ered concentration of serum oestradiol (E2). The serum 
concentrations of both E2 and PRL in females with good 
function of transplanted kidney are comparable with 
those observed in apparently healthy women [10, 25]. 
Most probably due to the normalisation of serum PRL 
concentration after kidney transplantation, the pulsa-
tile rhythm of FSH and oestrogen secretion returns to 
values close to normal, also a decrease in secretion of 
LH is observed.
As shown previously, in about 68% of women after 
successful KTx regular menstrual cycles occur, which 
is similarly frequent as in the general population [11, 
25, 26]. This is also in agreement with the results of 
the current study in which over 80% of females had 
regular menstrual cycles after the six-month observa-
tion period. 
Successful kidney transplantation tends to amelio-
rate the hormonal disturbances that occur in the course 
of CKD [10–12, 26–28]. One of the most important find-
ings in the endocrine balance in females after KTx is 
the decrease of improperly elevated in uraemia serum 
concentrations of LH and FSH [10, 12, 26, 27]. This is 
mostly in agreement with the results of our study, in 
which also a significant decrease of serum FSH and LH 
concentrations have been found. As far as serum LH 
concentration is concerned the baseline concentration 
was markedly higher in women awaiting the KTx and 
after six months. On the other hand, while the serum 
FSH concentration dropped, as predicted after the KTx, 
it was initially not significantly different from the serum 
FSH seen in the healthy controls. The difference became 
apparent after KTx, which caused the decrease of serum 
FSH concentration. Additionally, as both LH and FSH 
concentrations dropped to a similar extent, no significant 
differences in the FSH/LH ratio was seen in our study 
population pre- or post-KTx. The ratio was persistently 
significantly higher than in healthy controls.
Hyperprolactinaemia is often observed in women 
with CKD, as a result of the excessive production, de-
creased metabolism, and impaired excretion of PRL by 
the kidneys [1, 7, 9, 13, 16, 18, 19, 29]. The prevalence of 
hyperprolactinaemia increases along with the reduction 
of glomerular filtration and is most common in stage 
5 of CKD. Despite the fact that, as mentioned before, 
successful KTx tends to ameliorate most of the hormo-
nal disturbances linked to uraemia, there were no sig-
nificant differences but only a trend (p = 0.09) towards 
lower serum PRL concentration after KTx was found. 
Table II. Basic characteristics of the studied and control 
groups 
Tabela II. Podstawowa charakterystyka grup badanej 
i kontrolnej
Studied group 
(n = 10)
Control group 
(n = 46)
p
Age 
[years]
34.1 
(31.4–36.8)
31.3 
(29.5–33.1)
0.23
Time since first 
menstruation 
[years]
20.0 
(16.7–23.2)
17.9 
(16.0–19.8)
0.17
Irregular menstruation 
cycles 
[number of patients/%]
5/50% 6/13% 0.03
Time since the diagnosis 
of CKD 
[years]
13.9 
(6.2–21.5)
n/a
Mode of renal 
replacement treatment 
before KTx 
[number of patients/%]
 
8/80% 
n/a
haemodialysis 
peritoneal dialysis
 
2/20%
Time since the 
introduction of renal 
replacement treatment 
[months]
28.6 
(11.4–45.8)
n/a
BMI [kg/m2] 19.7 
(18.8–20.6)
22.6 
(21.3–24.0)
0.02
Systolic blood pressure 
[mmHg]
136.0 
(123.3–148.7)
115.6 
(110.8–120.5)
< 0.001
Diastolic blood pressure 
[mmHg]
83.5  
(74.6–92.4)
74.1 
(70.2–78.1)
0.02
BMI — body mass index, CKD — chronic kidney disease, KTx — kidney 
transplantation, n/a — not applicable
Table III. Blood haemoglobin concentration and serum 
creatinine, urea, glucose, total cholesterol, triglycerides, 
and total protein concentration in females before kidney 
transplantation (studied group) and in healthy controls
Tabela III. Stężenie hemoglobiny we krwi oraz kreatyniny, 
mocznika, glukozy, cholesterolu całkowitego, trójglicerydów 
i białka całkowitego w surowicy u kobiet przez przeszczepieniem 
nerki oraz w grupie kontrolnej
Studied group 
(n = 10)
Control group 
(n = 46)
p
Haemoglobin  
[g/dl]
11.03 
(10.26–11.80)
12.89  
(12.48–13.31)
< 0.001
Urea  
[mmol/l]
14.97  
(12.90–17.04)
4.61  
(4.25–4.98)
< 0.001
Glucose  
[mmol/l]
6.22  
(3.74–8.71)
4.45  
(4.25–4.65)
0.014
Total cholesterol 
[mmol/l]
5.18  
(4.30–6.06)
4.68  
(4.42–4.93)
< 0.001
Triglycerides 
[mmol/l]
1.59  
(1.31–1.88)
0.79  
(0.66–0.92)
< 0.001
Total protein  
[g/dl]
5.96  
(5.18–6.74)
7.04  
(6.89–7.20)
0.002
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This seems to be in contrast to some previous studies 
[12, 27, 30] but is probably caused by the modest number 
of enrolled patients and by the conservative statistical 
methods used in our study. Of note, even though the 
decrease of PRL did not reach significance the serum 
PRL concentrations found in women six months after 
KTx were no different from the serum PRL obtained 
from the healthy controls. 
In the current study no significant differences were 
found in the serum oestradiol concentrations between 
the haemodialysed woman and the control group. This 
is in agreement with the results of previous studies 
concerning this topic [13, 15, 27].
Among the drawbacks of our study the modest 
number of patients enrolled to the study group should 
be mentioned. This of course precluded the signifi-
cance of any correlation analyses. The size of the study 
group arises from the fact that a young woman is not 
a typical patient requiring renal replacement therapy. 
Also, women using hormonal contraception were not 
enrolled. It is worth mentioning, however, that even in 
this small group some significant differences of serum 
hormone concentrations were obtained.
In conclusion, we found that successful kidney 
transplantation leads to the normalisation of serum 
concentrations of the majority of hormones linked to 
fertility disorders in chronic kidney disease.
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